Sleep-Disordered Breathing: Clinical Trials

2 trials for Sleep-Disordered Breathing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Sleep-Disordered Breathing: new trials by email Literature Review of Sleep-Disordered Breathing trials Research Report on Sleep-Disordered Breathing

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Managing Opioid Related Sleep Apnea With Acetazolamide
Acetazolamide, Placebo - Sleep-Disordered Breathing, Obstructive Sleep Apnea
Phase 2CompletedUniversity of California, San Diego392023-10-182026-03-10
A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular Dysfunction
Acetazolamide, nasal Continuous Positive Airway Pressure (nCPAP) - Obstructive Sleep Apnea, Sleep-Disordered Breathing
Phase 2CompletedGöteborg University132014-03-012016-08-16

Narrower conditions

Sleep Apnea Syndromes (2)  ·  Sleep Apnea, Obstructive (2)  ·  Apnea (1)  ·  Chronic Pain (1)  ·  Hypertension (1)  ·  Respiration Disorders (1)  ·  Sleep Apnea, Central (1)  ·  Sleep Wake Disorders (1)

Broader conditions

Dyssomnias (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiratory Tract Diseases (2)  ·  Signs and Symptoms (2)  ·  Sleep Disorders, Intrinsic (2)  ·  Apnea (1)  ·  Cardiovascular Diseases (1)  ·  Mental Disorders (1)  ·  Pain (1)  ·  Respiration Disorders (1)  ·  Signs and Symptoms, Respiratory (1)  ·  Sleep Wake Disorders (1)  ·  Vascular Diseases (1)

Interventions

Acetazolamide (2)  ·  Continuous Positive Airway Pressure (1)

Sponsors

Göteborg University (1)  ·  University of California, San Diego (1)

Countries

Sweden (1)  ·  United States (1)

Top investigators

Jan Hedner, MD. Prof. (1)  ·  Jeremy Orr, MD (1)

Results publications

PMID 29510792

NIH funding

K23HL151880 (1)